Skip to main content

Table 1 Baseline characteristics by randomised group

From: Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial

 

SMS messaging

(N = 103)

Usual care

(N = 106)

Total

(N = 209)

 

Mean (SD), n (%) or Median (Q1, Q3)

Mean (SD) or n (%)

Mean (SD) or n (%)

Age(years)

63.9 (10.6)

63.9 (9.7)

63.9 (10.2)

Gender—female

42 (40.8)

44 (41.5)

86 (41.1)

Height (cm)

171.3 (9.6)

171.3 (9.8)

171.3 (9.7)

Weight (kg)

91.9 (21.7)

93.8 (17.5)

92.9 (19.6)

BMI (kg/m2)

31.3 (6.5)

32.0 (5.8)

31.6 (6.2)

Current Smoker

11 (10.7)

5 (4.7)

16 (7.7)

Duration of type 2 diabetes (years)

9.0 (3.2,15.0)

8.2 (4.5, 13.6)

8.8 (4.4, 14.3)

Receiving help with medication

3 (2.9)

3 (2.8)

6 (2.9)

Taking ≥ 5 medications (self-reported)

60 (58.3)

59 (55.7)

119 (56.9)

Ethnic group

White British

88 (85.4)

91 (85.8)

179 (85.6)

Indian

2 (1.9)

4 (3.8)

6 (2.9)

Pakistani

3 (2.9)

1 (0.9)

4 (1.9)

Caribbean

0 (0.0)

2 (1.9)

2 (1.0)

Chinese

1 (1.0)

0 (0.0)

1 (0.5)

African

0 (0.0)

1 (0.9)

1 (0.5)

Any mixed/multiple ethnic background

1 (1.0)

1 (0.9)

2 (1.0)

Other White background

4 (3.9)

2 (1.9)

6 (2.9)

Other South Asian

1 (1.0)

0 (0.0)

1 (0.5)

Other White British background

0 (0.0)

1 (0.9)

1 (0.5)

Other Asian

0 (0.0)

1 (0.9)

1 (0.5)

Other Black/African/Caribbean background

1 (1.0)

0 (0.0)

1 (0.5)

Other

1 (1.0)

0 (0.0)

1 (0.5)

Education group—n (%)

Some secondary education

20 (19.4)

4 (3.8)

24 (11.5)

GCSE/O-Levels

22 (21.4)

29 (27.4)

51 (24.4)

College, A-Levels, NVQ3 or below

15 (14.6)

24 (22.6)

39 (18.7)

Diploma, certificate, BTEC, NVQ 4 and above

15 (14.6)

21 (19.8)

36 (17.2)

Undergraduate degree (BA, BSc)

14 (13.6)

18 (17.0)

32 (15.3)

Post-graduate degree (MA, MSc)

13 (12.6)

7 (6.6)

20 (9.6)

Doctorate (PhD)

0 (0.0)

1 (0.9)

1 (0.5)

HbA1c (mmol/mol)

56.5 (14.7)

55.1 (12.3)

55.8 (13.5)

HbA1c (%)

7.3 (1.3)

7.2 (1.1)

7.3 (1.2)

Total cholesterol (mmol/L)

3.9 (0.9)

3.8 (0.7)

3.9 (0.8)

HDL cholesterol (mmol/L)

1.4 (0.7)

1.3 (0.5)

1.4 (0.6)

Ratio of total to HDL cholesterol

3.2 (1.3)

3.2 (1.0)

3.2 (1.2)

Systolic blood pressure (mmHg)

130.9 (13.4)

133.2 (14.6)

132.0 (14.1)

Diastolic blood pressure (mmHg)

76.3 (9.1)

76.2 (8.9)

76.2 (9.0)

Previous myocardial infarction

6 (5.8)

7 (6.6)

13 (6.2)

Stroke

1 (1.0)

2 (1.9)

3 (1.4)

Previous transient ischemic attack

1 (1.0)

3 (2.8)

4 (1.9)

Peripheral vascular disease

3 (2.9)

3 (2.8)

6 (2.9)

Renal Failure

2 (1.9)

1 (0.9)

3 (1.4)

Period owned or used a mobile phone

One year or less

0 (0.0)

1 (0.9)

1 (0.5)

One to 2 years

0 (0.0)

1 (0.9)

1 (0.5)

Two to 5 years

7 (6.8)

7 (6.6)

14 (6.7)

More than 5 years

95 (92.2)

97 (91.5)

192 (91.9)

Type of mobile phone

Smartphone

89 (86.4)

91 (85.8)

180 (86.1)

Standard mobile phone

14 (13.6)

15 (14.2)

29 (13.9)

EQ-5D-5L VASa

74.4 (19.9)

75.2 (15.2)

74.8 (17.6)

EQ-5D-5L Indexb

0.8 (0.2)

0.8 (0.2)

0.8 (0.2)

MARSc

22.9 (2.7)

23.7 (1.8)

23.3 (2.3)

  1. aScore ranges from 0 to 100, where 0 represents the “worst health you can imagine” and 100 represents the “best health you can imagine”
  2. bRange from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility
  3. cMedication adherence rating scale (five items). Score ranges from 5 to 25, where higher scores indicate better adherence